Various studies have confirmed that treatment with GB extract EGb 761 in murine AD models improves cognitive deficits and reduces Aβ aggregation or tau hyperphosphorylation in the brain [30–45], illustrating the therapeutic potential of ginkgolides and bilobalide in AD [46]. Here, MAPT is linked to Cognitive impairment.